Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
163 people get PBH articles and Market Currents by email alert.
Get email alerts on PBH »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
Prestige Brands Holdings, Inc. to Release Fiscal 2013 Fourth Quarter & Year-End Earnings on May 16thBusiness Wire (Apr 18, 2013)
-
Business Wire (Feb 5, 2013)
-
Business Wire (Jan 29, 2013)
-
Business Wire (Jan 21, 2013)
-
Business Wire (Jan 15, 2013)
-
Business Wire (Dec 20, 2012)
-
-
Prestige Brands: Solid Growth PickZacks Investment Research • Mon, Nov 12, 2012
-
Business Wire (Oct 31, 2012)
-
Business Wire (Oct 12, 2012)
-
Business Wire (Aug 7, 2012)
-
Business Wire (Jul 30, 2012)
-
-
Business Wire (Jul 16, 2012)
To learn more about Seeking Alpha Pro, click here.
-
8 Undervalued Healthcare Stocks With Strong Receivable TrendsKapitall • Thu, Jun 21, 2012 -
-
5 Stocks Posting Big Jumps On TuesdayAlex Shadunsky • Wed, Dec 21, 2011 -
Protect Your Portfolio With These 15 Defensive Healthcare StocksKurtis Hemmerling • Wed, Nov 23, 2011 -
20 Small-Cap Stocks Undervalued By The Graham NumberKapitall • Mon, Nov 21, 2011
-
10 Cash Rich, Profitable Firms In A Weak Consumer EnvironmentFollow My Alpha • Wed, Oct 26, 2011 -
5 More Big Sells By Donald YacktmanVatalyst • Wed, Sep 7, 2011 -
-
2 Buys and 1 Sell From Private Capital Management's Mutual FundsGuruFundPicks • Wed, Jun 22, 2011 -
Finding Moats in Big Pharma's Consumer Health UnitsMorningstar • Mon, Jun 13, 2011 -
-
Russell 2000's Most Attractive StocksValue Expectations • Mon, Apr 26, 2010 -
-
-
-
-
-
Prestige Brands Holdings, Inc. to Release Fiscal 2013 Fourth Quarter & Year-End Earnings on May 16thBusiness Wire (Apr 18, 2013)
-
Business Wire (Feb 5, 2013)
-
Business Wire (Jan 29, 2013)
-
Business Wire (Jan 21, 2013)
-
Business Wire (Jan 15, 2013)
-
Business Wire (Dec 20, 2012)
-
Business Wire (Oct 31, 2012)
-
Business Wire (Oct 12, 2012)
-
Business Wire (Aug 7, 2012)
-
Business Wire (Jul 30, 2012)
-
Business Wire (Jul 16, 2012)
-
at MarketWatch.com (May 17, 2012)
-
Prestige Brands Holdings, Inc. to Release Fiscal 2012 Fourth Quarter & Year-End Earnings on May 17thBusiness Wire (May 7, 2012)
-
Business Wire (May 3, 2012)
-
Business Wire (Apr 26, 2012)
PBH vs. ETF Alternatives
Company Description
Currently, there's no company description for PBH.
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Thursday, May 16, 8:47 AM Prestige Brands (PBH): FQ4 EPS of $0.36 beats by $0.01. FQ4 Revenue of $154.5M (+15.3% Y/Y) misses by $3.31M. FY13 EPS of $1.50 beats by $0.01. FY13 revenue of $623.6M misses by 3.43M. Shares -12.38% premarket. (PR) Comment! [Earnings, Healthcare, Consumer, On the Move]
- Thursday, February 7, 6:10 AM Prestige Brands (PBH): FQ3 EPS of $0.37 beats by $0.03. Revenue of $160.2M (+50.8% Y/Y) beats by $1.71M. (PR) Comment! [Earnings, Breaking News, Healthcare]
- Thursday, November 1, 2012, 3:16 PM Prestige Brands (PBH +20.3%) ramps higher after its FQ2 easily beat across the board this morning. Net earnings rose 53% Y/Y on revenue growth of 49%. The seller of brands such as Chloraseptic sore throat treatments, Clear Eyes eye-care products and Compound W wart treatments also boosted its per-share earnings guidance, now expecting its FY13 EPS to be around $1.37 - $1.42, above the consensus of $1.34. Comment! [Earnings, On the Move]
- Thursday, November 1, 2012, 6:29 AM Prestige Brand (PBH): Q3 EPS of $0.38 beats by $0.05. Revenue of $161.9M (+53.5% Y/Y) beats by $5M. (PR) Comment! [Earnings, Healthcare]
- Tuesday, August 7, 2012, 5:58 AM Prestige Brand (PBH): FQ1 EPS of $0.35 beats by $0.06. Revenue of $147M (+54.2% Y/Y) in-line. (PR) Comment! [Earnings, Healthcare]
- Friday, May 18, 2012, 1:24 PM Prestige Brands (PBH +1.5%) is higher today after Oppenheimer upgraded the stock to Outperform with a $17 price target. The firm believes the company is set to undergo a deleveraging process which will benefit investors. Separately, Janney Montgomery also ups the shares to Buy. Comment! [Healthcare]
- Thursday, May 17, 2012, 6:19 AM Prestige Brand (PBH): FQ4 EPS of $0.26 beats by $0.03. Revenue of $134M (+39% Y/Y) in-line. (PR) Comment! [Earnings, Healthcare]
- Thursday, May 3, 2012, 11:22 AM Shares of Prestige Brands (PBH -14.5%) are trading lower after Genomma Lab says it's decided to drop its proposed acquisition of the household cleaning products maker. Genoma says that despite satisfying PBH's conditions in its original buyout proposal, PBH unreasonably refused to continue discussions without an increase in the purchase price. Comment! [On the Move, M&A, Healthcare]
- Monday, March 12, 2012, 4:00 PM Prestige Brands (PBH +2%) rejects Genomma Lab's $834M unsolicited bid to acquire the maker of Comet and Spic n Span cleaners, calling it "inadequate." PBH adopts a shareholder rights plan in response to the bid, saying it would allow the board time and opportunity to consider any other that may be presented. Comment! [M&A, Healthcare, On the Move]
- Tuesday, February 21, 2012, 9:32 AM Prestige Brands (PBH) opens up 24% as Mexican pharma firm Genomma offers $16.60/share cash for the company ($834M excluding debt, a 23% premium). Genomma - due to report its Q4 results on Friday - would acquire Comet brand cleaning products along with healthcare lines like Clear Eyes contact lens solution. Comment! [Healthcare, M&A, On the Move]
-
Tuesday, February 21, 2012, 9:07 AM
Premarket gainers: CORT +61%. THLD +59%. PBH +24%. CTIC +11%. CHG +10%. STM +8%. SWC +8%. JASO +7%. WYNN +6%. IVAN +6%. SSN +5%. YGE +5%. HL +4%. IRE +4%. TSL +4%. FRO +3%. M +3%. HD +3%. DANG +3%. CS +3%. STP +3%. NG +3%.
Losers: GTXI -39%. CHTP -13%. WFT -11%. CTRP -9%. CIE -5%. NBG -5%. RIG -5%. CIEN -4%. WMT -3%. Comment! [On the Move] - Thursday, February 9, 2012, 6:38 AM More on Prestige Brand's (PBH) FQ3: OTC Healthcare segment revenue up 25.9% Y/Y to $84.9M led by sales of Little Remedies and The Doctor's, while Household Cleaning sales fell off 7.8% to $21.3M. Completes acquisition of 15 of the 17 brands it purchased from GlaxoSmithKline, with 2 set to be completed in H1. Expects the GSK buys to add $30M to FQ4 revenue and be neutral to EPS. (PR) Comment! [Earnings]
- Thursday, February 9, 2012, 6:17 AM Prestige Brand (PBH): FQ3 EPS of $0.25 in-line. Revenue of $106.3M (+17.3% Y/Y) beats by $3M. (PR) Comment! [Earnings, Healthcare]
- Wednesday, January 18, 2012, 2:11 PM Generic drugmaker Prestige Brands (PBH +3.9%) is trading higher after disclosing its FQ3 revenue rose 17% Y/Y, better than a 14.6% consensus. The company also claims its gross margin rose 16% Y/Y. Separately, Prestige is announcing a $290M debt offering; it partly plans to use the proceeds to finance its acquisition of 17 OTC drug brands from GlaxoSmithKline (GSK). Comment! [Healthcare, On the Move, Earnings]
- Friday, January 13, 2012, 2:37 PM Prestige Holdings (PBH -2.5%) announces a plan to offer a private placement of $290M of new senior notes to help finance the acquisition of 17 OTC drug brands from GlaxoSmithKline and retire existing debt. Comment! [On the Move, Healthcare]
- Tuesday, December 20, 2011, 9:52 AM Shares of Prestige Holdings (PBH) double up on a healthy premarket gain, and now stand 15.2% higher following the firm's acquisition of 17 consumer OTC brands from GlaxoSmithKline. Comment! [On the Move]
-
- View all 0 replies
-
Buffet_or_Broke
PBH (TSX) or PRBZF.PK, I've been long for a few years and has been fantastic performer plus juicy divs. Does anyone have any insight? - View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
Ryan Mallory
Mid Week Technical Watch - Ascending Triangle Break-outs: CALP GTXI ONE PBH TCAP http://bit.ly/m3a0TU - View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
LATEST REPLIES